Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Harmony Biosciences Holdings (HRMY) Other Non Operating Income (2020 - 2025)

Historic Other Non Operating Income for Harmony Biosciences Holdings (HRMY) over the last 6 years, with Q3 2025 value amounting to -$106000.0.

  • Harmony Biosciences Holdings' Other Non Operating Income rose 1451.61% to -$106000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$415000.0, marking a year-over-year decrease of 8201.75%. This contributed to the annual value of -$68000.0 for FY2024, which is 9930.37% up from last year.
  • Harmony Biosciences Holdings' Other Non Operating Income amounted to -$106000.0 in Q3 2025, which was up 1451.61% from -$193000.0 recorded in Q2 2025.
  • Harmony Biosciences Holdings' 5-year Other Non Operating Income high stood at $160000.0 for Q4 2024, and its period low was -$26.1 million during Q3 2021.
  • Moreover, its 5-year median value for Other Non Operating Income was -$20000.0 (2021), whereas its average is -$2.1 million.
  • Its Other Non Operating Income has fluctuated over the past 5 years, first soared by 95000.0% in 2022, then crashed by 1753928.57% in 2023.
  • Harmony Biosciences Holdings' Other Non Operating Income (Quarter) stood at -$26.1 million in 2021, then soared by 100.28% to $73000.0 in 2022, then crashed by 13478.08% to -$9.8 million in 2023, then soared by 101.64% to $160000.0 in 2024, then plummeted by 166.25% to -$106000.0 in 2025.
  • Its Other Non Operating Income stands at -$106000.0 for Q3 2025, versus -$193000.0 for Q2 2025 and -$276000.0 for Q1 2025.